Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CMV Reactivation”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Not applicableNo Longer AvailableNCT01945619
What this trial is testing

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

Who this might be right for
EBV InfectionCMV InfectionAdenoviral Infection
Baylor College of Medicine
Testing effectiveness (Phase 2)Study completedNCT00711035
What this trial is testing

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)

Who this might be right for
Adenovirus InfectionEBV Infection
Baylor College of Medicine 50
Not applicableStudy completedNCT05898048
What this trial is testing

CMV Reactivation in Acute Necrotizing Pancreatitis

Who this might be right for
Acute Necrotizing Pancreatitis
Sanjay Gandhi Postgraduate Institute of Medical Sciences 41
Testing effectiveness (Phase 2)Study completedNCT00562770
What this trial is testing

Oral Valganciclovir Versus Valacyclovir

Who this might be right for
Chronic Lymphocytic LeukemiaLeukemia
M.D. Anderson Cancer Center 46
Not applicableLooking for participantsNCT07609576
What this trial is testing

Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.

Who this might be right for
Lymphoma NeoplasmsMyeloma MultipleSevere Infection+3 more
Infanta Leonor University Hospital 350
Testing effectiveness (Phase 2)Looking for participantsNCT02532452
What this trial is testing

Third Party Viral Specific T-cells (VSTs)

Who this might be right for
Viral InfectionViral ReactivationInfection in an Immunocompromised Host
Children's Hospital Medical Center, Cincinnati 750
Not applicableLooking for participantsNCT04030676
What this trial is testing

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

Who this might be right for
Cytomegalovirus Infections
Centre Hospitalier Universitaire de Saint Etienne 196
Not applicableStudy completedNCT02527291
What this trial is testing

Cytomegalovirus Reactivation in Non Immunocompromised Patients Undergoing Cardiac Surgery

Who this might be right for
Cardiac Surgery
Soroka University Medical Center 30
Early research (Phase 1)UnknownNCT03576014
What this trial is testing

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

Who this might be right for
Cytomegalovirus InfectionsPreventation of Cytomegalovirus ReactivationBK Virus Infection+1 more
SL VAXiGEN 18
Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Early research (Phase 1)Looking for participantsNCT05183490
What this trial is testing

R-MVST Cells for Treatment of Viral Infections

Who this might be right for
Epstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenovirus+1 more
Columbia University 36
Testing effectiveness (Phase 2)Looking for participantsNCT02048332
What this trial is testing

Donor-Derived Viral Specific T-cells (VSTs)

Who this might be right for
Allogeneic Stem Cell TransplantViral InfectionViral Reactivation
Children's Hospital Medical Center, Cincinnati 750
Not applicableUnknownNCT02874157
What this trial is testing

Evaluation of Methods for Diagnosis of Cytomegalovirus Pneumonia in Mechanically Ventilated Patient

Who this might be right for
CMV Reactivation Diagnosis in ICU Patient
Assistance Publique Hopitaux De Marseille 450
Not applicableLooking for participantsNCT06058858
What this trial is testing

Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis

Who this might be right for
Cytomegalovirus InfectionsAcute LeukemiaB Cell Lymphoma
Assistance Publique - Hôpitaux de Paris 250
Testing effectiveness (Phase 2)Study completedNCT02227641
What this trial is testing

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Patients Undergoing Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 50
Testing effectiveness (Phase 2)Study completedNCT04312841
What this trial is testing

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 6
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Testing effectiveness (Phase 2)Looking for participantsNCT03594981
What this trial is testing

Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis

Who this might be right for
Viral Infection
Catherine Bollard 36
Post-approval studies (Phase 4)UnknownNCT05914675
What this trial is testing

Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT

Who this might be right for
The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
Institute of Hematology & Blood Diseases Hospital, China 21
Testing effectiveness (Phase 2)UnknownNCT01633476
What this trial is testing

CMV Modulation of the Immune System in ANCA-associated Vasculitis

Who this might be right for
ANCA Associated VasculitisCMV Infection
Professor Lorraine Harper 38
Load More Results